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ABSTRACT 
Objective: To evaluate the analgesic effect and anti-inflammatory properties of Boswellia dalzielii (Burseraceae), a medicinal plant commonly used 
in northern Nigeria as an anti-diarrhoeal, antipyretic, analgesic and anti-inflammatory agent. 
Methods: Three doses (25 mg/kg, 50 mg/kg and 100 mg/kg) of the crude aqueous extract of Boswellia dalzielii were evaluated for analgesic and 
anti-inflammatory activities using the acetic acid-induced writhing test, formalin-induced nociception and formalin-induced hind paw oedema in 
rats. The acute oral toxicity was carried out using the up and down procedure as described by the OECD guidelines. 
Results: All doses (25, 50 and 100 mg/kg) of the extract tested were effective against acetic acid induced abdominal constrictions producing a 
percentage inhibition of (55.43, 69.56 and 71.73%) respectively. A percentage inhibition of the formalin-induced nociception of (7.31, 31.70 and 
48.78%-early phase) and (12.82, 21.79 and 48.71%-late phase) respectively was also produced. For the acetic acid writhing test, the percentage 
inhibition obtained at the dose of 50 and 100 mg/kg (69.56 and 71.73%) were higher than that of the standard drug (Piroxicam, 10 mg/kg) 
(59.78%). For formalin-induced nociception, the test extract at 100 mg/kg showed a higher percentage inhibition compared to Piroxicam, in early 
(48.78 and 43.90%) and late phase (48.71 and 39.74 %) respectively. The extract, however, did not show a significant activity against formalin-
induced paw oedema at all the doses used. 
Conclusion: The present study demonstrated that Boswellia dalzielii has significant analgesic properties comparable to that of the standard drug 
(10% Piroxicam), thus validating the traditional claim of its antinociceptive property. 
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Inflammation is part of the complex biological response of body 
tissues to harmful stimuli, such as pathogens, damaged cells, or 
irritants [1]. The purpose of inflammation is to eliminate the initial 
cause of cell injury, clear out necrotic cells and tissues damaged from 
the original insult and the inflammatory process, and to initiate tissue 
repair [1]. Pain (Algesia) on the other hand is an unpleasant sensation 
that can negatively affect all areas of a person's life, including comfort, 
thought, sleep, emotion, and normal daily activity [2]. The side effects 
of some of the currently available drugs for the management of these 
conditions pose a major problem in their clinical use. For example, 
some non-steroidal anti-inflammatory drugs (NSAIDs) may cause 
gastric ulceration and renal damage [3, 4]. Owing to the safety 
concerns associated with the use of synthetic anti-inflammatory and 
analgesic agents, those of natural sources are desired [5]. 
Boswellia dalzielii (Frankincense) is a tree plant that is abundantly 
found in north-western Nigeria, where the Hausa speaking people 
refer to it as Hano or Arrabi [6]. This plant is very popular among 
the locals as a potent source of ethnomedicine [6]. A previous 
preliminary survey on the local use of Boswellia dalzielii among ten 
herbalist from Kano and Sokoto states in the northwestern region of 
Nigeria reveals that, the aqueous stem bark extract of Boswellia 
dalzielii is used in the treatment of gastrointestinal problems 
(diarrhea and abdominal cramp) and as antipyretic, analgesic and 
anti-inflammatory agent either alone or in combination with other 
herbs (unpublished data). Etuk et al. has shown that the aqueous 
stem bark extract of Boswellia dalzielii possesses anti-diarrheal 
activity [7]. The stem bark has also been shown to have an 
antispasmodic activity [8]. While the aqueous extract of the stem 
bark produced some anti-ulcer activity [9]. 
The claimed analgesic, and anti-inflammatory activity of the stem 
bark extract has however not been found in the literature. This study 
was therefore carried out to evaluate the analgesic and anti-
inflammatory activity of the aqueous stem bark extract of Boswellia 
dalzielii and validate its ethnobotanical use for this purpose. 
MATERIALS AND METHODS 
Animals 
Wistar rats weighing about 110-160 g and mice weighing (20-25 g) 
of both sexes were used for the experiment. The wistar rats were 
obtained from the animal house of Ahmadu Bello University Zaria, 
while the mice were obtained from the animal house of Faculty of 
Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto. The 
animals were maintained under standard environmental conditions, 
fed with standard chow and had access to food and water ad libitum. 
The animals were acclimatized for two weeks before the 
commencement of the study. The study was approved by the 
Research Ethics Committee, Usmanu Danfodiyo University, Sokoto. 
The care of the rats was conducted in accordance with established 
public health guidelines for handling experimental animals. 
Chemicals and drugs 
Formalin and acetic acid were obtained from Sigma Chemical Co. (St 
Loius, MO, USA) while Piroxicam (Feldene® by Pfizer Inc, New 
York,) was obtained from a local Pharmacy. 
Plant collection and identification 
The plant was collected from Bare village, in Gezawa local 
government, Kano state, on 12th May 2015. It was identified at the 
herbarium unit of the Department of Pharmacognosy and 
Ethnopharmacy, Usmanu Danfodiyo University, Sokoto, and 
authenticated by Dr. Halilu Mshelia. The plant was given a voucher 
number PCG/UDUS/BURS/0001 and preserved in the herbarium for 
future reference.  
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Preparation of the extract 
The bark was air dried for about 10 d and then size reduced using 
mortar and pestle. Two hundred gram (200 g) of the powdered bark 
was cold macerated with 1.5 l of distilled water for 72 h. The extract 
was filtered and transferred into an evaporating dish of known 
weight. It was evaporated to dryness in a hot air oven at 40 °C. The 
percentage yield was then determined. 
Acute toxicity studies 
Limit test at 2000 mg/kg as described by the Organisation for 
Economic Co-operation and Development (OECD) guidelines [11] for 
oral acute toxicity testing was used. All experimental animals were 
maintained under close observation for 14 d.  
Anti-inflammatory studies 
The formalin (2.5%) induced inflammation as described by Winter 
et al. (1962) [12] was used in this study. Animals were divided into 5 
groups of 5 rats each. Thirty minutes before the injection of 
formalin, the first group received distilled water (1 ml/kg), groups 
2-4 received 25, 50 and 100 mg/kg intraperitoneally (i. p) of the 
extract respectively. The fifth group received 10 mg/kg i. p of 
piroxicam. The increase in paw diameter was measured using 
vernier caliper (Digital caliper, Skole®0-150 mm, model number 
605035 from Frits Pedersen, Denmark). The difference in the weight 
of the right hind paw and the left hind paw indicates inflammation. 
The measurement was done immediately before and after 1-5 h 
following formalin injection. 
Analgesic studies 
Acetic acid induced writhing test in mice 
This test was conducted employing the method described by Koster et al. 
[13], employing abdominal constriction. Swiss albino mice were divided 
into five (5) groups each containing five (5) mice. The first group was 
given 10 ml/kg of distilled water intra-peritoneal and served as the 
negative control, groups 2,3 and 4 received 25, 50 and 100 mg/kg body 
weight respectively of the aqueous extract of Boswellia dalzielii stem 
bark intraperitoneally,while the fifth group received piroxicam (10 
mg/kg), intraperitoneally. Thirty (30) minutes later, mice in all the 
groups were treated with acetic acid (1% acetic acid of 1 ml per kg body 
weight, i. p.). Five minutes after acetic acid injection, mice were placed in 
individual cages and the number of abdominal contraction was counted 
for each mouse for a period of 10 min. Percentage inhibition of writhing 
was calculated using the formula:  
 
Formalin-induced nociception in rats 
The formalin-induced pain test in rats as described by Duduisson 
and Dennis [14] which involves recording the severity of pain as a 
score was used. Animals were grouped into 5 groups of 5 animals 
each. Distilled water (10 ml/kg intraperitoneal) was given to group 
1 to serve as negative control. The aqueous extract (25, 50 and 100 
mg/kg intraperitoneal) was given to groups 2, 3 and 4, respectively. 
Piroxicam (10 ml/kg intraperitoneal) was given to group 5 to serve 
as positive control. Thirty (30) minutes post-treatment, 0.05 ml of 
2.5% formalin was injected under the planter surface of the left hind 
paw. The rats were then placed in transparent boxes for 
observation. The severity of the pain was recorded as scores: (0), rat 
walked or stood firmly on the injected paw: (1), rat partially 
elevated or favoured the paw: (2), rat elevated the paw from the 
floor: or (3), rat licked, bit or shook the paw. The cut off point for the 
observation were every 2 min for the first 10 min (early phase) and 
at every 5 min for the period between 10th and 60th minute (late 




The results of the experiment are represented as mean±standard 
error of the mean (SEM). The results were analyzed using GraphPad 
instant version 3 software and student’s t-test was employed for 
comparing the means between groups. Differences were considered 
to be significant at p<0.05. 
RESULTS 
Percentage yield of the plant extract 
The total weight of the extract obtained was 13 g and it was 
extracted from 200 g of the powdered stem bark of Boswellia 
dalzielii. The percentage yield of the plant extract was calculated to 
be 6.5%. 
Acute toxicity studies 
A single oral administration of the extract (2000 mg/kg) caused 
restlessness, itching of the mouth, and sleep in all the animals and no 
mortality occurred within 24 h after administration and after 
fourteen days observation. The LD50 of the stem bark extract of 
Boswellia dalzielii is, therefore, more than 2000 mg/kg. 
Acetic acid induced writhing test 
The results of the inhibition of acetic acid-induced abdominal 
writhing in rats are presented as mean±SEM. Boswellia dalzielii at 
the dose of 25, 50 and 100 mg/kg exhibited a significant inhibition 
of the writhing at the rate of 55.43, 69.56 and 71.73% respectively. 
The standard drug piroxicam (10 mg/kg) also produce a significant 
inhibition of the acetic acid writhing with a percentage inhibition of 
59.78%. The percentage inhibition obtained at the dose of 50 and 
100 mg/kg (69.56 and 71.73%) were higher than that of the 
standard drug piroxicam (59.78%). This is shown in table 1. 
 
Table 1: Effect of Boswellia Dalzielii on acetic acid induced writhing response 
Treatments Dose (mg/kg) i. p. No. of abdominal writhing % Inhibition 
Distilled water 10 (ml/kg) 18.4±1.97 0.00 
Boswellia dalzielii 25 8.2±2.01* 55.43 
Boswellia dalzielii 50 5.6±1.17* 69.56 
Boswellia dalzielii 100 5.2±0.58* 71.73 
Piroxicam 10 7.4±3.12* 59.78 
Data presented as mean±SEM, n= 5 for all groups, *Significantly different from the control at p<0.05 
 
Formalin induced nociception 
The aqueous extract of Boswellia dalzielii stem bark significantly 
inhibited the first phase (neurogenic pain) of the formalin-induced 
pain in rats at the dose 50 and 100 mg/kg in a dose-dependent 
manner. The percentage inhibitions obtained were 7.31, 31.70 and 
48.78% for 25, 50, and 100 mg of the extract respectively. The 
extract also produced a significant inhibition of the late phase at the 
dose of 50 and 100 mg/kg. The percentage inhibitions of the extract 
in the late phase were 12.82, 21.79 and 39.74% for 25, 50 and 100 
mg/kg respectively. When compared to the positive control 
(piroxicam 10 mg/kg), the test extract at 100 mg/kg showed a 
higher percentage inhibition in early (43.90 and 48.78%) and late 
phase (39.74 and 48.71), respectively (table 2). 
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Table 2: Effect of Boswellia dalzielii on formalin induced pain in rats 
Treatment (mg/kg) Early phase pain score % inhibition Late phase pain score % inhibition 
Distilled water 10 ml/kg  1.64±0.19 - 1.56±0.09 - 
Boswellia dalzielii 25 1.52±0.17 7.31 1.36±0.09 12.82 
Boswellia dalzielii 50 1.12±0.07* 31.70 1.22±0.09* 21.79 
Boswellia dalzielii 100 0.84±0.11* 48.78 0.8±0.11* 48.71 
Piroxicam 10 0.92±0.14* 43.90 0.94±0.07* 39.74 
Data presented as mean±SEM, n= 5 for all groups, *Significantly different from the control at p<0.05Anti-inflammatory studies, the aqueous extract 
of Boswellia dalzielii did not produce a significant inhibition of the formalin induced inflammation at all doses used throughout the period of the 
study (table 3). 
 
Table 3: Anti-Inflammatory activity of Boswellia Dalzielii in rat 
Treatment (mg/kg) 1st h 2nd h  3rd h 4th h 5th h 
Distilled water (10 ml/kg) 0.65±0.36 1.37±0.41 1.62±0.25 1.37±0.45 1.38±0.38 
Boswellia dalzielii 25 0.73±0.21 1.92±0.45 2.10±0.54 1.88±0.33 1.53±0.16 
Boswellia dalzielii 50 0.74±0.24 1.32±0.14 1.39±0.37 1.14±0.14 0.74±0.23 
Boswellia dalzielii 100 0.80±0.30 1.52±0.27 1.68±0.28 1.53±0.34 1.14±0.19 
Piroxicam 10 1.41±0.38 1.37±0.23 1.44±0.43 1.18±0.30 0.88±0.23 
Data presented as mean±SEM, n= 5 for all groups, *Significantly different from the control at p<0.05 
 
DISCUSSION 
The percentage yield obtained after aqueous extraction of powdered 
Boswellia dalzielii bark was found to be 6.5%. This result is similar to 
previous studies where it was shown to have a percentage yield of 
6.8% [9]. 
The oral median lethal dose value of the extract in rats using the up 
and down procedure was found to be>2000 mg/kg. A previous study 
showed that at doses ≤ 2000 mg/kg per oral administration of 
aqueous extract of Boswellia dalzielii, no obvious behavioural 
changes or toxicity signs or even death were seen within the 
observation period of 72 h and the LD50 was>2000 mg/kg [7]. The 
LD50 value obtained shows that the bark extract of Boswellia dalzielii 
is relatively non-toxic and therefore safe for use. The LD50 value also 
justifies its use traditionally without any observed toxic effect.  
In the analgesic studies, acetic acid induced writhing test and formalin-
induced pain in rats were used. The acetic acid-induced writhing test 
is very sensitive and able to detect anti-nociceptive effects of 
compounds at dose levels that may appear inactive in other methods 
like tail flick test [15]. However, the test is not specific as it does not 
indicate whether the activity was central and/or peripheral [16]. The 
intraperitoneal injection of acetic acid produces an abdominal 
writhing response due to sensitization of chemosensitive nociceptors 
by prostaglandins [17]. Deraedt et al. [18] described the quantification 
of prostaglandins in the peritoneal exudates of rats by 
radioimmunoassay, obtained after intraperitoneal injection of acetic 
acid. They found high levels of prostaglandins PGE2α e PGF2α during 
the first 30 min after acetic acid injection. Nevertheless, it was found 
that intraperitoneal administration of acetic acid induces not only the 
liberation of prostaglandins but also the liberation of sympathetic 
nervous system mediators [19 and 20]. The extract (25, 50 and 100 
mg/kg) significantly inhibited acetic acid-induced writhing in mice in a 
dose-dependent manner,with the extract at the highest dose (100 
mg/kg) showing a higher percentage inhibition compared with 
piroxicam (10 mg/kg) which is the standard analgesic used in the 
study. Similar studies conducted on Caralluma dalzielii [21], 
Schwenckia Americana [22] and Mimosa pudica [23] showed that they 
all dose-dependently reduced the number of writhing episodes of mice 
in comparison with that of vehicle-treated animals. This is, however, in 
contrast with the result of Okechukwu et al. [24] where cassava leaves 
extract significantly inhibited abdominal writhing in mice, in a non-
dose dependent manner. The analgesic effect of the extract may, 
therefore, be due either to its action on visceral receptors sensitive to 
acetic acid, to the inhibition of the production of algogenic substances 
or the inhibition at the central level of the transmission of painful 
messages [22].  
The formalin-induced model is very useful for elucidating the 
mechanism of pain and analgesia [25]. The formalin test has a 
distinctive biphasic nociceptive response termed early and late 
phases. Drugs that act primarily on the central nervous system 
inhibit both phases equally while peripherally acting drugs inhibit 
the late phase [16]. The first phase (neurogenic phase) is probably a 
direct result of stimulation of nociceptors in the paw. Stimulation of 
opioid receptors has also been suggested as a possible mechanism of 
action against neurogenic pain [26]. This phase, therefore, reflects 
centrally mediated pain while the late phase (inflammatory phase) is 
due to inflammation with the release of serotonin, histamine, 
bradykinin and prostaglandins and at least to some degree, the 
sensitization of central nociceptive neurons [25]. The crude aqueous 
extract of Boswellia dalzielii exerted a significant, dose-dependent 
suppression of both phases as observed in the dose tested (50 and 
100 mg/kg) suggesting the presence of both central and peripheral 
effects. However, the extract has a greater inhibitory effect on the 
neurogenic pain (early phase). A previous study carried out on 
Caralluma dalzielii showed that the extract inhibited the two phases 
of formalin-induced pain, suggesting suppression of both neurogenic 
and inflammatory nociception, and thus possess both central and 
peripheral mechanism [21]. The result obtained in Caralluma 
dalzielii is similar to that obtained with Boswellia dalzielii in terms of 
its analgesic properties. Also in a study using the methanolic extract 
of Schwenckia americana, a significant inhibition of the early phase 
and late phase of the formalin-induced pain model in rats was 
observed [22]. The result is similar to that obtained in this studies 
except that, Boswellia dalzielii produced a significant inhibition at 50 
and 100 mg only while Schwenckia americana produced a significant 
inhibition at all the doses (25, 50 and 100 mg/kg). 
The formalin-induced edema model was used in the anti-
inflammatory studies. Acute inflammation induced by formaldehyde 
results from cell damage, which provokes the production of 
endogenous mediators, such as, histamine, serotonin, prostaglandins 
and bradykinin [27]. This acute inflammatory response is usually 
biphasic comprising of an early neurogenic phase mediated by 
substance P and bradykinin followed by a tissue mediated response 
where histamine, 5-HT, prostaglandins and bradykinin are known to 
be involved [28]. It is well known that inhibition of edema induced 
by formaldehyde in rats is one of the best suitable test procedures 
for sub-acute anti-inflammatory agents as it closely resembles 
human inflammation [29]. Inflammation induced by formaldehyde is 
also a model used for the evaluation of an agent with probable anti-
proliferative activities [30]. In the current study, the aqueous extract 
of Boswellia dalzielii did not produce a significant reduction in the 
inflammatory growth in the hind paw of the rats at all the three 
doses used (25, 50 and 100 mg/kg). In contrast, a study on the anti-
inflammatory properties of Terminalia brownii demonstrated a 
dose-dependent response to carrageenan-induced paw edema 
induced inflammation [31]. Also, Boswellia serrata a related plant 
Adebisi et al. 
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has been evaluated for analgesic and anti-inflammatory activity [32]. 
The different fractions of Boswellia serrata, essential oil (10 ml/kg), 
gum (100 mg/kg, resin (100 mg/kg) oleo-resin (100 mg/kg) and 
oleo-gum-resin (100 mg/kg) significantly reduced carrageenan-
induced inflammation in rats and showed analgesic activity, as 
determined by acetic acid induced writhing response, formalin-
induced pain, hot plate and tail flick method [32]. 
CONCLUSION 
These results demonstrate that the crude aqueous extract of 
Boswellia dalzielii possesses analgesic but does not show anti-
inflammatory activity. The research also supports the ethnomedical 
claim of the use of macerated Bosellia dalzielii bark as a pain 
reliever. The study also suggests the presence of ingredients with 
the potentials of being developed into analgesic agents. Further 
studies are needed for the confirmation of the mechanism of action 
of analgesia and to find out the active constituents responsible for 
this property. 
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